FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称GOMILIXIMAB
异名/同义词GOMILIXIMAB
GOMILIXIMAB [USAN]
IDEC-152
IMMUNOGLOBULIN G1, ANTI-(HUMAN IMMUNOGLOBULIN E RECEPTOR TYPE II) (HUMAN-MACACA IRUS MONOCLONAL IDEC-152 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MACACA IRUS MONOCLONAL IDEC-152 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1, ANTI-(HUMAN IMMUNOGLOBULIN E RECEPTOR TYPE II) (HUMAN-MACACA IRUS MONOCLONAL IDEC-152 .GAMMA.1-CHAIN), DISULPHIDE WITH HUMAN-MACACA IRUS MONOCLONAL IDEC-152 .KAPPA.-CHAIN, DIMER
LUMILIXIMAB
LUMILIXIMAB [INN]
LUMILIXIMAB [MART.]
LUMILIXIMAB [WHO-DD]
PRIMATIZED ANTI-CD23
ST-152
CAS登记号357613-86-6
物质唯一标识(Unique Ingredient Identifier)8Z13S29R5A
分子式
国际化合物标识(International Chemical Identifier,InChI)
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / protein
关联数据
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System